• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗前体成分表型与上皮性卵巢癌死亡率的关系。

The association of body composition phenotypes before chemotherapy with epithelial ovarian cancer mortality.

机构信息

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

出版信息

J Natl Cancer Inst. 2024 Sep 1;116(9):1513-1524. doi: 10.1093/jnci/djae112.

DOI:10.1093/jnci/djae112
PMID:38802116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11378317/
Abstract

BACKGROUND

The association of body composition with epithelial ovarian carcinoma (EOC) mortality is poorly understood. To date, evidence suggests that high adiposity is associated with decreased mortality (an obesity paradox), but the impact of muscle on this association has not been investigated. Herein, we define associations of muscle and adiposity joint-exposure body composition phenotypes with EOC mortality.

METHODS

Body composition from 500 women in the Body Composition and Epithelial Ovarian Cancer Survival Study was dichotomized as normal or low skeletal muscle index (SMI), a proxy for sarcopenia, and high or low adiposity. Four phenotypes were classified as fit (normal SMI and low adiposity; reference; 16.2%), overweight or obese (normal SMI and high adiposity; 51.2%), sarcopenia and overweight or obese (low SMI and high adiposity; 15.6%), and sarcopenia or cachexia (low SMI and low adiposity; 17%). We used multivariable Cox models to estimate associations of each phenotype with mortality for EOC overall and high-grade serous ovarian carcinoma (HGSOC).

RESULTS

Overweight or obesity was associated with up to 51% and 104% increased mortality in EOC and HGSOC [Hazard Ratio (HR)] = 1.51, 95% CI = 1.05 to 2.19 and HR = 2.04, 95% CI = 1.29 to 3.21). Sarcopenia and overweight or obesity was associated with up to 66% and 67% increased mortality in EOC and HGSOC (HR = 1.66, 95% CI = 1.13 to 2.45 and HR = 1.67, 95% CI = 1.05 to 2.68). Sarcopenia or cachexia was associated with up to 73% and 109% increased mortality in EOC and HGSOC (HR = 1.73, 95% CI = 1.14 to 2.63 and HR = 2.09, 95% CI = 1.25 to 3.50).

CONCLUSIONS

Overweight or obesity, sarcopenia and overweight or obesity, and sarcopenia or cachexia phenotypes were each associated with increased mortality in EOC and HGSOC. Exercise and dietary interventions could be leveraged as ancillary treatment strategies for improving outcomes in the most fatal gynecological malignancy with no previously established modifiable prognostic factors.

摘要

背景

体成分与上皮性卵巢癌(EOC)死亡率之间的关系尚未完全阐明。迄今为止,有证据表明肥胖与死亡率降低(肥胖悖论)有关,但肌肉对这种关联的影响尚未得到研究。在此,我们定义了肌肉和脂肪联合暴露的体成分表型与 EOC 死亡率之间的关联。

方法

对来自 Body Composition and Epithelial Ovarian Cancer Survival Study 中的 500 名女性的体成分进行二分法,分为正常或低骨骼肌指数(SMI),这是肌少症的代表,以及高或低肥胖。将四种表型分为健康型(正常 SMI 和低肥胖;参考;16.2%)、超重或肥胖型(正常 SMI 和高肥胖;51.2%)、肌少症和超重或肥胖型(低 SMI 和高肥胖;15.6%)以及肌少症或恶液质型(低 SMI 和低肥胖;17%)。我们使用多变量 Cox 模型来估计每种表型与 EOC 总体和高级别浆液性卵巢癌(HGSOC)死亡率之间的关联。

结果

超重或肥胖与 EOC 和 HGSOC 死亡率分别增加了 51%和 104%(风险比(HR)= 1.51,95%置信区间(CI)= 1.05 至 2.19 和 HR = 2.04,95%CI = 1.29 至 3.21)。肌少症和超重或肥胖与 EOC 和 HGSOC 死亡率分别增加了 66%和 67%(HR = 1.66,95%CI = 1.13 至 2.45 和 HR = 1.67,95%CI = 1.05 至 2.68)。肌少症或恶液质与 EOC 和 HGSOC 死亡率分别增加了 73%和 109%(HR = 1.73,95%CI = 1.14 至 2.63 和 HR = 2.09,95%CI = 1.25 至 3.50)。

结论

超重或肥胖、肌少症和超重或肥胖、以及肌少症或恶液质这三种表型与 EOC 和 HGSOC 的死亡率增加均相关。运动和饮食干预可以作为辅助治疗策略,用于改善这种尚无先前确定的可改变预后因素的最致命妇科恶性肿瘤的结局。

相似文献

1
The association of body composition phenotypes before chemotherapy with epithelial ovarian cancer mortality.化疗前体成分表型与上皮性卵巢癌死亡率的关系。
J Natl Cancer Inst. 2024 Sep 1;116(9):1513-1524. doi: 10.1093/jnci/djae112.
2
Clinically relevant body composition phenotypes are associated with distinct circulating cytokine and metabolomic milieus in epithelial ovarian cancer patients.临床上相关的身体成分表型与上皮性卵巢癌患者不同的循环细胞因子和代谢组学环境相关。
Front Immunol. 2024 Nov 7;15:1419257. doi: 10.3389/fimmu.2024.1419257. eCollection 2024.
3
Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.应用 CT 标准化相位测量肌肉对晚期卵巢癌患者的预后价值。
Nutrition. 2020 Apr;72:110642. doi: 10.1016/j.nut.2019.110642. Epub 2019 Nov 9.
4
Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.计算机断层扫描测量的肌肉和脂肪与非转移性乳腺癌患者生存的关联。
JAMA Oncol. 2018 Jun 1;4(6):798-804. doi: 10.1001/jamaoncol.2018.0137.
5
The impact of body composition on treatment in ovarian cancer: a current insight.体成分对卵巢癌治疗的影响:当前的认识。
Expert Rev Clin Pharmacol. 2021 Sep;14(9):1065-1074. doi: 10.1080/17512433.2021.1937125. Epub 2021 Jun 8.
6
The effect of body mass index on survival in advanced epithelial ovarian cancer.体重指数对晚期上皮性卵巢癌患者生存的影响。
J Korean Med Sci. 2014 Jun;29(6):793-7. doi: 10.3346/jkms.2014.29.6.793. Epub 2014 May 30.
7
Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.原发性减瘤手术和化疗过程中的肌肉丢失可预测晚期卵巢癌的不良预后。
J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):534-546. doi: 10.1002/jcsm.12524. Epub 2020 Jan 30.
8
Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer.通过CT扫描测量的肌肉组成是晚期卵巢癌总体生存的可测量预测指标。
Gynecol Oncol. 2016 Aug;142(2):311-6. doi: 10.1016/j.ygyno.2016.05.027. Epub 2016 Jun 2.
9
Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.骨骼肌衰减(肌肉减少症)预测接受初次肿瘤细胞减灭术的晚期上皮性卵巢癌患者总生存期缩短。
Ann Surg Oncol. 2018 Oct;25(11):3372-3379. doi: 10.1245/s10434-018-6683-3. Epub 2018 Aug 1.
10
Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.根据体质量指数评估化疗剂量对卵巢癌生存的影响。
JAMA Oncol. 2015 Sep;1(6):737-45. doi: 10.1001/jamaoncol.2015.1796.

引用本文的文献

1
The role of diet, obesity and body composition in epithelial ovarian cancer development and progression: Mechanisms and therapeutic implications.饮食、肥胖和身体成分在上皮性卵巢癌发生发展中的作用:机制及治疗意义
Gynecol Oncol Rep. 2025 Mar 16;58:101718. doi: 10.1016/j.gore.2025.101718. eCollection 2025 Apr.
2
Clinically relevant body composition phenotypes are associated with distinct circulating cytokine and metabolomic milieus in epithelial ovarian cancer patients.临床上相关的身体成分表型与上皮性卵巢癌患者不同的循环细胞因子和代谢组学环境相关。
Front Immunol. 2024 Nov 7;15:1419257. doi: 10.3389/fimmu.2024.1419257. eCollection 2024.

本文引用的文献

1
TotalSegmentator: Robust Segmentation of 104 Anatomic Structures in CT Images.全段分割器:CT图像中104种解剖结构的稳健分割
Radiol Artif Intell. 2023 Jul 5;5(5):e230024. doi: 10.1148/ryai.230024. eCollection 2023 Sep.
2
Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy.宿主肥胖改变卵巢肿瘤免疫微环境,并影响对标准护理化疗的反应。
J Exp Clin Cancer Res. 2023 Jul 12;42(1):165. doi: 10.1186/s13046-023-02740-y.
3
Cancer cachexia: molecular mechanisms and treatment strategies.癌症恶病质:分子机制与治疗策略。
J Hematol Oncol. 2023 May 22;16(1):54. doi: 10.1186/s13045-023-01454-0.
4
Whole-Body Composition Features by Computed Tomography in Ovarian Cancer: Pilot Data on Survival Correlations.卵巢癌患者通过计算机断层扫描得出的全身成分特征:生存相关性的初步数据
Cancers (Basel). 2023 May 4;15(9):2602. doi: 10.3390/cancers15092602.
5
Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer.高风险乳腺癌治疗前、治疗期间和治疗后 2 年内对癌症预防生活方式建议的坚持情况。
JAMA Netw Open. 2023 May 1;6(5):e2311673. doi: 10.1001/jamanetworkopen.2023.11673.
6
Survival and immunotoxicities in association with sex-specific body composition patterns of cancer patients undergoing immune-checkpoint inhibitor therapy - A systematic review and meta-analysis.接受免疫检查点抑制剂治疗的癌症患者的生存情况及与性别特异性身体成分模式相关的免疫毒性——一项系统评价和荟萃分析
Eur J Cancer. 2023 May;184:151-171. doi: 10.1016/j.ejca.2023.01.030. Epub 2023 Feb 18.
7
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management.肥胖与癌症:流行病学、发病机制、结局及管理现状综述
Cancers (Basel). 2023 Jan 12;15(2):485. doi: 10.3390/cancers15020485.
8
Effectiveness of combined nutrition and exercise interventions on body weight, lean mass, and fat mass in adults diagnosed with cancer: a systematic review and meta-analysis.联合营养和运动干预对癌症诊断成年人的体重、瘦体重和体脂肪的效果:系统评价和荟萃分析。
Nutr Rev. 2023 May 10;81(6):625-646. doi: 10.1093/nutrit/nuac079.
9
Quantifying the inflammatory secretome of human intermuscular adipose tissue.定量分析人类肌间脂肪组织的炎症分泌组。
Physiol Rep. 2022 Aug;10(16):e15424. doi: 10.14814/phy2.15424.
10
Adiposity and cancer survival: a systematic review and meta-analysis.肥胖与癌症生存:系统评价和荟萃分析。
Cancer Causes Control. 2022 Oct;33(10):1219-1246. doi: 10.1007/s10552-022-01613-7. Epub 2022 Aug 15.